The Use of Proteomics in Biomarker Discovery in Neurodegenerative Diseases

Biomarkers for neurodegenerative diseases should reflect the central pathogenic processes of the diseases. The field of clinical proteomics is especially well suited for discovery of biomarkers in cerebrospinal fluid (CSF), which reflects the proteins in the brain under healthy conditions as well as...

Descripción completa

Detalles Bibliográficos
Autores principales: Davidsson, Pia, Sjögren, Magnus
Formato: Online Artículo Texto
Lenguaje:English
Publicado: IOS Press 2005
Materias:
Other
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3850612/
https://www.ncbi.nlm.nih.gov/pubmed/15920295
http://dx.doi.org/10.1155/2005/848676

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3850612/
https://www.ncbi.nlm.nih.gov/pubmed/15920295
http://dx.doi.org/10.1155/2005/848676

Ejemplares similares